Drugs Made In America Acquisition Corp.

(NASDAQ) DMAAR

Current Price$0.11

Market CapN/A

Since IPO (2025)-33%

5 YearN/A

1 Year-22%

1 Month-26%

Drugs Made In America Acquisition Corp. Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$6.66M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.11

Volume

9,906

Open

$0.12

Price

$0.11

Volume

9,906

Open

$0.12

Previous Close

$0.10

Daily Range

$0.10 - $0.12

52-Week Range

$0.10 - $0.12

Estimated Earnings Date

May 20, 2025

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.11

Volume

9,906

Open

$0.12

Previous Close

$0.10

Daily Range

$0.10 - $0.12

52-Week Range

$0.10 - $0.12

Estimated Earnings Date

May 20, 2025

DMAAR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drugs Made In America Acquisition Corp.

Industry

Capital Markets

Sector

Financials

Headquarters

Fort Lauderdale, FL 33301, US

DMAAR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-1%

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

9.91K

Avg. Volume

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.82M

EBITDA

-$2.82M

Operating Cash Flow

-$539.19K

Capital Expenditure

$0.00

Free Cash Flow

-$539.19K

Cash & ST Invst.

$6.14K

Total Debt

$0.00

Drugs Made In America Acquisition Corp. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.97M

+57.1%

EBITDA

-$143.30K

+56.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$85.11K

-41.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$100.00K

+64.2%

Return on Assets

2.75%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

-$91.25K

+63.7%

Operating Cash Flow

-$91.25K

+63.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EGHAEGH Acquisition Corp. Class A Ordinary Shares

EGHAEGH Acquisition Corp. Class A Ordinary Shares$10.30-0.10%

APADRA Paradise Acquisition Corp. Rights

APADRA Paradise Acquisition Corp. Rights$1.00+0.00%

VNMEVendome Acquisition Corporation I

VNMEVendome Acquisition Corporation I$10.22+0.20%

SCAGScage Future American Depositary Shares

SCAGScage Future American Depositary Shares$0.84+194.58%

ATMVAlphaVest Acquisition Corp

ATMVAlphaVest Acquisition Corp$10.30+31.30%

TAVIRTavia Acquisition Corp.

TAVIRTavia Acquisition Corp.$0.10-17.16%

AVTAAvantax, Inc.

AVTAAvantax, Inc.$25.99+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

Questions About DMAAR

What is the current price of Drugs Made In America Acquisition Corp.?

Drugs Made In America Acquisition Corp. is trading at $0.10 per share.

What is the 52-week range for Drugs Made In America Acquisition Corp.?

Over the past 52 weeks, Drugs Made In America Acquisition Corp. has traded between $0.10 and $0.12.

How much debt does Drugs Made In America Acquisition Corp. have?

Drugs Made In America Acquisition Corp. total debt is unavailable.

How much cash does Drugs Made In America Acquisition Corp. have on hand?

Drugs Made In America Acquisition Corp. does not have cash on hand data available.

What is Drugs Made In America Acquisition Corp.’s dividend yield?

Drugs Made In America Acquisition Corp. does not currently have a dividend yield.

Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. Financials at a Glance

DMAAR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Drugs Made In America Acquisition Corp.

DMAAR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Drugs Made In America Acquisition Corp. Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DMAAR

What is the current price of Drugs Made In America Acquisition Corp.?

What is the 52-week range for Drugs Made In America Acquisition Corp.?

How much debt does Drugs Made In America Acquisition Corp. have?

How much cash does Drugs Made In America Acquisition Corp. have on hand?

What is Drugs Made In America Acquisition Corp.’s dividend yield?

Premium Investing Services